Jackson Acquisition Company II (JACS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JACS SEC filings page.
This page shows Jackson Acquisition Company II (JACS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
The filing describes an acquisition vehicle, not an operating business: nearly all reported assets are matched by liabilities, leaving little equity cushion.
Because no revenue or gross profit is reported, net income of$9.1M cannot be read as a sales-and-cost operating result; paired with an operating loss of$569K , it indicates earnings came from items outside the operating line. That distinction makes ordinary margin and cash-conversion measures poor descriptions of this entity’s economics.
At FY2025 year-end, total assets were
Reported operating cash flow was
Financial Health Signals
Jackson Acquisition Company II does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
For every $1 of reported earnings, Jackson Acquisition Company II used $0.05 of operating cash (-$428K OCF vs $9.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Jackson Acquisition Company II reported $2.0M in net income in Q2 2026. This represents a decrease of 14.6% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Jackson Acquisition Company II held $358K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
JACS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
JACS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $247.3M+3.6% | $245.2M+3.8% | $243.2M+3.9% | $240.9M+124217.0% | $238.6M | $236.3M | $234.0M | $194K |
| Current Assets | $444K-48.1% | $526K-43.3% | $633K-40.4% | $694K+21267.3% | $857K | $928K | $1.1M | $3K |
| Cash & Equivalents | $358K-50.3% | $393K-48.0% | $522K-45.0% | $585K | $722K | $756K | $949K | N/A |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Long-Term Investments | $246.8M+3.8% | $244.7M | $242.5M+4.2% | $240.2M | $237.7M | $0 | $232.9M | N/A |
| Total Liabilities | $247.4M+3.9% | $245.2M+4.0% | $243.0M+4.2% | $240.6M+110081.7% | $238.2M | $235.7M | $233.2M | $218K |
| Current Liabilities | $576K+30.7% | $473K+16.9% | $412K+15.3% | $386K | $441K | $405K | $358K | N/A |
| Non-Current Liabilities | $246.8M+3.8% | $244.7M+4.0% | $242.5M+4.2% | $240.2M | $237.7M | $235.3M | $232.9M | N/A |
| Total Equity | -$132K-129.1% | $52K-91.0% | $221K-72.1% | $325K+1422.4% | $455K | $584K | $790K | -$25K |
| Retained Earnings | -$133K-129.3% | $52K-91.1% | $220K-42.2% | $324K+754.1% | $454K | $583K | $381K | -$50K |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
JACS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
JACS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | N/A | 3752.2%+3370.5pp | N/A | 722.1% | 510.1% | 381.7% | 48.3% | N/A |
| Return on Assets | 0.8%-0.2pp | 0.8%-0.1pp | N/A | 1.0% | 1.0% | 0.9% | 0.2% | N/A |
| Current Ratio | 0.77-1.2x | 1.11-1.2x | 1.54-1.4x | 1.80 | 1.94 | 2.29 | 2.97 | N/A |
| Debt-to-Equity | N/A | 4671.56+4267.6x | 1100.59+805.3x | 740.57 | 524.04 | 403.91 | 295.26 | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Jackson Acquisition Company II JACS | FY2025 | N/A | $9.1M | N/A | $319.6M | — |
| Drugs Made In America Acquisition Corp. Units DMAAU | FY2025 | N/A | $5.9M | N/A | N/A | — |
| Andretti Acquisition Corp. II POLE | FY2025 | N/A | $8.4M | N/A | $147.1M | — |
| Graf Global Corp. GRAF | FY2025 | N/A | $8.0M | N/A | $153.2M | — |
| Archimedes Tech SPAC Partners II Co. ATII | FY2025 | N/A | $8.0M | N/A | $316.3M | — |
Where Jackson Acquisition Company II Ranks
Frequently Asked Questions
Is Jackson Acquisition Company II profitable?
Yes, Jackson Acquisition Company II (JACS) reported a net income of $9.1M in fiscal year 2025.
What is Jackson Acquisition Company II's return on equity (ROE)?
Jackson Acquisition Company II (JACS) has a return on equity of 4129.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Jackson Acquisition Company II's operating cash flow?
Jackson Acquisition Company II (JACS) recorded an outflow of $428K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Jackson Acquisition Company II's total assets?
Jackson Acquisition Company II (JACS) had $243.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Jackson Acquisition Company II's current ratio?
Jackson Acquisition Company II (JACS) had a current ratio of 1.54 as of fiscal year 2025, which is generally considered healthy.
What is Jackson Acquisition Company II's debt-to-equity ratio?
Jackson Acquisition Company II (JACS) had a debt-to-equity ratio of 1100.59 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Jackson Acquisition Company II's return on assets (ROA)?
Jackson Acquisition Company II (JACS) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Jackson Acquisition Company II's P/E ratio?
Jackson Acquisition Company II (JACS) trades at 35.1x earnings, its market capitalization divided by net income of $9.1M net income, FY2025. The market capitalization is $319.6M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Jackson Acquisition Company II's price-to-sales ratio?
Jackson Acquisition Company II (JACS) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $319.6M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Are Jackson Acquisition Company II's earnings high quality?
For every $1 of reported earnings, Jackson Acquisition Company II (JACS) used $0.05 of operating cash (-$428K OCF vs $9.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.